News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kovacs Shane William Charles
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Kovacs Shane William Charles (CH. OPERATING & FINANCIAL OFF.) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $0 |
|
| 11/19/2020 |
4
| Kovacs Shane William Charles (Ch. Operating & Financial Off.) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 358,680 shares
@ $0
Granted 107,604 options to buy
@ $19, valued at
$2M
|
|
| 11/18/2020 |
3
| Kovacs Shane William Charles (Ch. Operating & Financial Off.) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
| 05/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/26/2016 |
4
| Kovacs Shane William Charles (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Exercised 10,000 options to buy
@ $10.85, valued at
$108.5k
|
|
| 01/06/2016 |
4
| Kovacs Shane William Charles (EVP, CFO & Head of Corp Dev) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 80,000 options to buy
@ $30.86, valued at
$2.5M
|
|
| 05/22/2015 |
4
| Kovacs Shane William Charles (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 64,041 shares
@ $55.26, valued at
$3.5M
Sold 18,450 shares
@ $55.93, valued at
$1M
Exercised 60,375 options to buy
@ $10.85, valued at
$655.1k
Exercised 18,616 options to buy
@ $27.05, valued at
$503.6k
|
|
| 01/02/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/23/2014 |
4
| Kovacs Shane William Charles (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 1,650 shares
@ $14.74, valued at
$24.3k
|
|
| 01/31/2014 |
4
| Kovacs Shane William Charles (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 65,000 options to buy
@ $27.05, valued at
$1.8M
|
|
| 06/19/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|